The alcohol-associated hepatitis treatment landscape
Medical management of alcohol-associated hepatitis has remained largely unchanged since the 1970 s. However, promising therapies targeting multiple aspects of pathophysiology are on the horizon, including a planned phase 3 trial for larsucosterol, an active phase 2a study with INT-787 and a planned trial using F-652.
Authors
- Amon Asgharpour (ORCID: https://orcid.org/0000-0002-3545-8703)
- Hanna Blaney (ORCID: https://orcid.org/0000-0003-4919-9519)
Institutions
- Virginia Commonwealth University (US)
- Bon Secours Liver Institute of Richmond (US)
Publication Details
- Journal
- Current Opinion in Gastroenterology
- Published
- 2026-02-15
- DOI
- https://doi.org/10.1097/mog.0000000000001158
- Primary Topic
- Alcohol Consumption and Health Effects
- Type
- article
- Field-Weighted Citation Impact
- 0.00